Mohammad Mahdi Eftekharian

Mohammad Mahdi Eftekharian

Auto-generated profile, based on publicly available information

Mohammad Mahdi Eftekharian

Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
MEMohammad Mahdi Eftekharian
Mohammad Mahdi Eftekharian
SGSoudeh Ghafouri-Fard
Soudeh Ghafouri-Fard
MSMohammad Soudyab
Mohammad Soudyab
MOMir Davood Omrani
Mir Davood Omrani
MRMahnoosh Rahimi
Mahnoosh Rahimi
Mohammad TaheriMohammad Taheri
Mohammad Taheri

1 October 2016 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
MEMohammad Mahdi Eftekharian
Mohammad Mahdi Eftekharian
RNRezvan Noroozi
Rezvan Noroozi
ASArezou Sayad
Arezou Sayad
SSShaghayegh Sarrafzadeh
Shaghayegh Sarrafzadeh
MTMehdi Toghi
Mehdi Toghi
RMReza Mirfakhraie
Reza Mirfakhraie

1 January 2017 in Gene
Verified
Journal Article
Closed access
MSMohammad Reza Safari
Mohammad Reza Safari
SGSoudeh Ghafouri-Fard
Soudeh Ghafouri-Fard
RNRezvan Noroozi
Rezvan Noroozi
ASArezou Sayad
Arezou Sayad
MOMir Davood Omrani
Mir Davood Omrani
Mohammad TaheriMohammad Taheri
Mohammad Taheri

8 June 2016 in Human Antibodies
Verified
Journal Article
Closed access
PDF file
MEMohammad Mahdi Eftekharian
Mohammad Mahdi Eftekharian
MGMasoud Sabouri Ghannad
Masoud Sabouri Ghannad
Mohammad TaheriMohammad Taheri
Mohammad Taheri
GRGhodratollah roshanaei
Ghodratollah roshanaei
MMMehrdokht Mazdeh
Mehrdokht Mazdeh
MHMona Bahmani Hormoz
Mona Bahmani Hormoz
OBJECTIVES: Multiple sclerosis (MS) is a complicated disease which occurs due to relationship between genes and environmental factors that causes tissue damage by autoimmune mechanisms. We investigated and illustrated the hypotheses correlated to the

1 May 2016 in Human Antibodies
Verified
Journal Article
Closed access
PDF file
MEMohammad Mahdi Eftekharian
Mohammad Mahdi Eftekharian
ASArezou Sayad
Arezou Sayad
MOMir Davood Omrani
Mir Davood Omrani
MGMasoud Sabouri Ghannad
Masoud Sabouri Ghannad
RNRezvan Noroozi
Rezvan Noroozi
Mohammad TaheriMohammad Taheri
Mohammad Taheri
BACKGROUND: Although Multiple Sclerosis (MS) is an autoimmune multifactorial disease with unknown etiology, various genetic and environmental factors are known to contribute to the pathogenesis of the disease. OBJECTIVE: Recent studies have confirmed that the suppressive function of regulatory T cells (T (reg)) is impaired in MS patients and that the FOXP3 gene is a crucial transcription factor in the regulation of CD4+CD25+FOXP3+ Treg cells. Polymorphisms in the promoter region of the FOXP3 gene may alter the gene expression level and, therefore, contribute to the disease susceptibility. METHODS: The present study aimed to investigate the possible association between single nucleotide polymorphisms (SNPs) rs3761548 and rs2232365 in the FOXP3 gene and predisposition to MS. We conducted a case-control study on 410 patients with sporadic MS and 446 healthy controls. Genotyping was performed using polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP). RESULTS: Significant differences in distribution of both rs3761548 and rs2232365 A allele were found in MS patients in comparison to controls. Haplotype frequencies were also different among the studied groups. The A-A and C-G haplotype blocks showed a significant difference between case and controls. CONCLUSION: we have provided further evidence for the association between genetic variations and haplotypes in FOXP3 and MS in Iranian population.

1 January 2014 in Indian Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
ASAli Shamsizadeh
Ali Shamsizadeh
RVReza Vazirinejad
Reza Vazirinejad
FAFatemeh Ayoobi
Fatemeh Ayoobi
MAMohammad Kazemi Arababadi
Mohammad Kazemi Arababadi
MEMohammad M Eftekharian
Mohammad M Eftekharian
DKDerek Kennedy
Derek Kennedy
Objective: Achillea millefolium (A. millefolium) is widely used as an anti-inflammatory remedy in traditional and herbal medicine. In this study, we investigated the effect of an aqueous extract from A. millefolium on experimental autoimmune encephalomyelitis (EAE) and on the serum cytokine levels in C57BL/6 mice. Materials and Methods: EAE was induced in 63 C57BL/6 mice weighing 20-25 g (8 weeks old). Following immunization, the treatment protocol was initiated by using different doses of an aqueous extract from A. millefolium (1, 5, and 10 mg/mouse/day). Histopathologic assessments were performed by hematoxylin and eosin (H and E) and luxol fast blue (LFB) staining. Behavioral disabilities were recorded by a camera. Serum levels of interleukin (IL)-10, IL-12, and transforming growth factor (TGF)-β were measured using enzyme-linked immunosorbent assay (ELISA). Results: On average, mice developed classical behavioral disabilities of EAE, 13.2 ± 1.9 days following immunization. Treatment of mice with A. millefolium led to delay the appearance of behavioral disabilities along with reduced severity of the behavioral disabilities. Treatment with A. millefolium prevented weight loss and increased serum levels of TGF-β in immunized mice with MOG35-55. EAE-induced mice, which were treated with A. millefolium, had less cerebral infiltration of inflammatory cells. Conclusion: The results demonstrated that treatment with aqueous extract of A. millefolium may attenuate disease severity, inflammatory responses, and demyelinating lesions in EAE-induced mice. In addition, following treatment with A. millefolium, serum levels of TGF-βwere increased in EAE-induced mice.